Showing results (2181-2190 of 25,162) with videos related to

Sort By:
Pageof 2,517
Oncotarget|September 8, 2018
Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancerMaiko Niki, Aya Nakaya, Takayasu Kurata, et al.
Oncotarget|September 8, 2018
Correction: Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cellsChristian Schütz, Juan Carlos Varela, Karlo Perica, et al.
Oncotarget|July 25, 2018
TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin ASin Ying Cheung, Matthias Henrot, Mohammad Al-Saad, et al.
Oncotarget|July 25, 2018
Polymorphism of regulatory region of APEH gene (c.-521G>C, rs4855883) as a relevant predictive factor for radiotherapy induced oral mucositis and overall survival in head neck cancer patientsAnna Brzozowska, Radosław Mlak, Iwona Homa-Mlak, et al.
Oncotarget|July 25, 2018
A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancersVino T Cheriyan, Hashem Alsaab, Sreeja Sekhar, et al.
Oncotarget|July 25, 2018
TRAF3IP2, a novel therapeutic target in glioblastoma multiformeEckhard U Alt, Zahra Barabadi, Andreas Pfnür, et al.
Oncotarget|July 25, 2018
Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancerNoomi Vainer, Christian Dehlendorff, Julia S Johansen
Oncotarget|July 26, 2018
Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11Hironaga Satake, Yu Sunakawa, Yuji Miyamoto, et al.
Oncotarget|July 26, 2018
Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastomaSaurabh Agarwal, Giorgio Milazzo, Kimal Rajapakshe, et al.
Oncotarget|June 5, 2018
HIV-1 integrase strand-transfer inhibitor resistance in southern TaiwanHung-Chin Tsai, I-Tzu Chen, Kuan-Sheng Wu, et al.
Pageof 2,517